Manuela Schweiger is currently the Director of RA CMC at Sandoz Biopharmaceuticals, a position held since 2022. Previously, Manuela served as Associate Director RA CMC from 2018 to 2022 and has held various roles including Senior Regulatory Affairs Manager and Head Registration Anti-Infectives. Manuela completed a postdoctoral fellowship in Supramolecular Chemistry at the University of Utah from 1999 to 2001 and earned a degree at Leopold-Franzens Universität Innsbruck between 1989 and 1998.
Location
Austria
This person is not in the org chart
This person is not in any teams
This person is not in any offices